Session Track · IDC 2027 · Track 07

Dermatological Therapeutics at IDC 2027

Part of the IDC 2027 scientific program · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Dermatological Therapeutics Session

Skin disorders have had a significant impact on people's quality of life around the world, resulting in lost productivity at work and other places, as well as discrimination due to disfigurement. Changes in the skin could signal the presence of more significant skin disorders that need to be treated. The treatment and prevention of disorders of the skin, hairs, nails and genitals are the focus of dermatological therapy. There are numerous administration routes; however, topical is the most commonly used, followed by oral and other ways. The Dermatological Therapeutics Market is competitive but not overly so. As a result of several potential prospects, many new players are entering the dermatological therapeutics market. The upcoming patent expirations of major pharmaceuticals are causing increasing competition, which is driving the market studied even higher, particularly in the generic sector. The dermatological diagnostics and therapeutics sector as a whole is predicted to grow rapidly, with some generic players commanding a large portion of the market in developing countries. 

Featured Speakers — Dermatological Therapeutics 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Dermatological Therapeutics Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Dermatological Therapeutics Conference 2027

Present Your Research

Oral and poster slots for original Dermatological Therapeutics work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Dermatological Therapeutics research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join IDC 2027 for the Dermatological Therapeutics track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Dermatological Therapeutics Conference 2027 — FAQs

What is the Dermatological Therapeutics track at IDC 2027?

The Dermatological Therapeutics track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Dermatological Therapeutics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Dermatological Therapeutics sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Dermatological Therapeutics are all welcome — whether presenting or attending.

Can I present my research in the Dermatological Therapeutics track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Dermatological Therapeutics sessions?

Yes. IDC 2027 is a hybrid conference — attend the Dermatological Therapeutics track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.